Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OPNT

Opiant Pharmaceuticals (OPNT) Stock Price, News & Analysis

Opiant Pharmaceuticals logo

About Opiant Pharmaceuticals Stock (NASDAQ:OPNT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$20.03
$21.10
52-Week Range
N/A
Volume
562,700 shs
Average Volume
77,920 shs
Market Capitalization
$108.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opiant Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

OPNT Stock News Headlines

Movers From Yesterday
Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
Hikma Pharmaceuticals PLC ADR (HKMPY)
Ionis Pharmaceuticals
See More Headlines

OPNT Stock Analysis - Frequently Asked Questions

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) released its quarterly earnings data on Thursday, November, 11th. The technology company reported $0.56 EPS for the quarter, beating analysts' consensus estimates of $0.15 by $0.41. The technology company had revenue of $16.34 million for the quarter, compared to analysts' expectations of $12.45 million. Opiant Pharmaceuticals had a negative trailing twelve-month return on equity of 97.03% and a negative net margin of 147.90%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Opiant Pharmaceuticals investors own include NIO (NIO), Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), Cara Therapeutics (CARA), Dynavax Technologies (DVAX) and AcelRx Pharmaceuticals (ACRX).

Company Calendar

Last Earnings
11/11/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OPNT
CIK
1108924
Employees
37
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($6.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.01 million
Net Margins
-147.90%
Pretax Margin
-147.84%
Return on Equity
-97.03%
Return on Assets
-59.66%

Debt

Debt-to-Equity Ratio
0.60
Current Ratio
5.48
Quick Ratio
5.48

Sales & Book Value

Annual Sales
$47.78 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
24.75
Book Value
$9.92 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
5,270,000
Free Float
3,865,000
Market Cap
$108.83 million
Optionable
Not Optionable
Beta
0.84

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:OPNT) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners